Although blood levels of HMGB1 increased in AKI regardless of TLR4 mutation, anti-HMGB1 neutralizing antibody treatment reduced lung injury only in the wild-type mice, indicating the organ protecting effect was mediated by the HMGB1-TLR4 pathway. The gene discussed is TLR4; the disease is acute kidney injury.